BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

LAX-101: Completed Phase III enrollment

Amarin completed enrollment of 702 patients with high triglyceride levels (200-500 mg/dL) who are on statin therapy in the double-blind, U.S. Phase III ANCHOR trial...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >